Investigation of Antibiotic Resistance Profiles of Acinetobacter Strains Isolated from ICU Samples in Mashhad, Iran (October ۲۰۱۸–May ۲۰۱۹)

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 155

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JABS-15-4_007

تاریخ نمایه سازی: 14 آبان 1404

چکیده مقاله:

Background & Objectives: Acinetobacter spp. are non-fermentative, Gram-negative, opportunistic pathogens characterized by high levels of antibiotic resistance and are frequently associated with nosocomial infections in intensive care units (ICUs). This study aimed to investigate the antibiotic resistance profiles of Acinetobacter strains isolated from ICU patients using the BD Phoenix system, which determines antimicrobial susceptibility based on the Minimum Inhibitory Concentration (MIC) method. Materials & Methods: A descriptive, cross-sectional study was conducted from October ۲۰۱۸ to May ۲۰۱۹ involving ۶۰ ICU patients at Mehr-e Hazrat Abbas Hospital in Mashhad, Iran. Clinical specimens—including blood, bronchoalveolar lavage, tracheal secretions, wound swabs, biopsies, pleural fluid, and sternum swabs—were collected under sterile conditions. Acinetobacter species were identified through standard culture techniques and confirmed via PCR targeting the blaOXA-۵۱-like gene. Antimicrobial susceptibility testing against ۲۱ antibiotics was performed using the BD Phoenix system in accordance with CLSI guidelines. Data were analyzed using SPSS software employing chi-square tests (p < ۰.۰۵). Results: All ۶۰ isolates were confirmed as Acinetobacter spp. Colistin demonstrated the highest susceptibility rate (۹۰%). The highest resistance rates were observed against aminoglycosides, carbapenems, and quinolones (each ۵۵%), followed by cephalosporins, macrolides, and β-lactamase inhibitors (۵۴%), sulfonamides (۴۳%), and monobactams (۴۰%). Multidrug-resistant A. baumannii represents a serious threat in ICUs owing to its environmental persistence, genetic adaptability, and plasmid-mediated resistance mechanisms. Although colistin remains one of the most effective therapeutic options, its use is limited by toxicity and the emergence of resistance. Conclusion: The findings underscore the alarming rise in antibiotic resistance among Acinetobacter strains and highlight the necessity of implementing targeted antibiotic stewardship programs and localized surveillance systems to optimize treatment outcomes and curb the spread of resistance.

نویسندگان

تهمینه قانعی یزدی

Department of Biology, Kavian Institute of Higher Education, Mashhad, Iran

نازنین عطایی

Department of Biology, Kavian Institute of Higher Education, Mashhad, Iran

پرستو تاج زاده

Department of Medical Laboratory Sciences, Kashmar Faculty of Medical Sciences, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran

مسعود چابکسوار

Kavian Institute of Higher Education, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Zarrilli R, Giannouli M, Tomasone F, Triassi M, Tsakris A. ...
  • Lynch III JP, Zhanel GG, Clark NM, editors. Infections due ...
  • Shields RK, Clancy CJ, Gillis LM, Kwak EJ, Silveira FP, ...
  • Michalopoulos A, Falagas ME. Treatment of Acinetobacter infections. Expert Opin. ...
  • Vázquez-López R, Solano-Gálvez SG, Juárez Vignon-Whaley JJ, Abello Vaamonde JA, ...
  • Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas M, ...
  • Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter ...
  • Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence ...
  • Manchanda V, Sanchaita S, Singh N. Multidrug resistant Acinetobacter. J. ...
  • Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms ...
  • Serwecińska L. Antimicrobials and antibiotic-resistant bacteria: a risk to the ...
  • Turton J, Gabriel S, Valderrey C, Kaufrnann M, Pitt T. ...
  • Whiteway C, Breine A, Philippe C, Van der Henst C. ...
  • Dent LL, Marshall DR, Pratap S, Hulette RB. Multidrug resistant ...
  • Ibrahim S, Al-Saryi N, Al-Kadmy IM, Aziz SN. Multidrug-resistant Acinetobacter ...
  • Tagueha AD, D’Agostini C, Scribano D, Fiorilla C, Limongi D, ...
  • Scoffone V.C, Trespidi G, Barbieri G, Arshad A, Israyilova A, ...
  • Dhanapal B, Kumar R, Mehta P. Emerging drug resistance in ...
  • Tagueha AD, Romano M, Esposito S. Genomic adaptation of Carbapenem-resistant ...
  • Lin M-F, Lan C-Y. Antimicrobial resistance in Acinetobacter baumannii: From ...
  • Boutzoukas A, Doi Y. Global epidemiology of Carbapenem-resistant Acinetobacter baumannii: ...
  • Tagueha AD, Romano M, Esposito S. Genomic adaptation of Carbapenem-resistant ...
  • Vrancianu CO, Gheorghe I, Czobor IB, Chifiriuc MC. Antibiotic resistance ...
  • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: Emergence of ...
  • Thomsen J, Al-Mansoori H, Elhadi M, Al Kaabi S. Epidemiology ...
  • Beig M, Rahimi S, Alavi SM, Ghaffari S. Geographical mapping ...
  • Dubey V, Sharma A, Gupta N. Drug-resistant Acinetobacter baumannii: mortality ...
  • Hatami R. The frequency of multidrug-resistance and extensively drug-resistant Acinetobacter ...
  • Maleki A, Kaviar VH, Koupaei M, Haddadi MH, Kalani BS, ...
  • Villalón P, Valdezate S, Medina-Pascual MJ, Rubio V, Vindel A, ...
  • World Health Organization. Global antimicrobial resistance and use surveillance system ...
  • Khaledi A, Fatemeh D, Javad Hosseini SM, Meskini M, Esmaeili ...
  • Almaghrabi MK, Joseph MR, Assiry MM, Hamid ME. Multidrug-resistant Acinetobacter ...
  • Indian Council of Medical Research. Annual AMR surveillance report. New ...
  • Tagueha AD, D'Agostini C, Scribano D, Fiorilla C, Limongi D, ...
  • نمایش کامل مراجع